Department of the Army, DoD.
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/290,725 entitled “Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus,” filed December 29, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
The invention relates generally to the field of Start Printed Page 3901antibodies. More specifically the invention relates to monoclonal antibodies against glycoproteins of the Ebola Sudan Boniface virus and methods of producing and using the same.Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-1314 Filed 1-22-10; 8:45 am]
BILLING CODE 3710-08-P